<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_British_Columbia_Naringenin skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:British Columbia/Naringenin</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="collapse navbar-collapse" id="navbarSupportedContent" style="margin-right:20px;"><UL class="navbar-nav ml-auto right-buffer"><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
            PROJECT
          </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown" style="width:240px;"><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Description">OVERVIEW</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Naringenin">DISTRIBUTED BIOSYNTHESIS</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Biosensor">BIOSENSOR</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Kaempferol">POPULATION DYNAMICS</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Parts">PARTS</A></DIV></LI><LI class="nav-item"><A class="nav-link" href="https://2018.igem.org/Team:British_Columbia/Model">MODEL</A></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
            HUMAN PRACTICES
          </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown" style="width:200px;"><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Human_Practices">HUMAN PRACTICES</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Public_Engagement">PUBLIC ENGAGEMENT</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Collaborations">COLLABORATIONS</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
            TEAM
          </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Team">MEMBERS</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Attributions">ATTRIBUTIONS</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
            LABORATORY
          </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Notebook">NOTEBOOK</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/Protocols">PROTOCOLS</A><A class="dropdown-item" href="https://2018.igem.org/Team:British_Columbia/InterLab">INTERLAB</A></DIV></LI><LI class="nav-item"><A class="nav-link" href="https://2018.igem.org/Team:British_Columbia/Deliverables">ACHIEVEMENTS</A></LI></UL></DIV><DIV id="in-content"><DIV class="container"><DIV class="row"><P>
Maintaining elevated production and activity levels of enzymes in an engineered biosynthetic pathway is a significant metabolic burden for the host cell.  This burden is exacerbated when different enzymes within a biosynthetic pathway have varied or competing environmental and nutrient dependencies, like redox state <SUP>1, 2</SUP>.
</P><P>
Through the expression of 6 exogenous genes, E. coli is able to convert glucose into kaempferol, a flavonol that acts as an antioxidant and has been reported to have anti-cancer properties <SUP>3, 4</SUP>.
Biosynthesis of kaempferol involves the conversion of tyrosine into p-coumaric acid, malonyl-CoA dependent production of the flavanone naringenin and subsequent functionalization into kaempferol <SUP>3-5</SUP>.</P><P>This pathway was split into two biosynthetic modules, with naringenin acting as an intermediate that can be transferred between co-culture members.  This co-culture design is especially effective in the context of kaempferol production as biosynthetic module 1 (naringenin biosynthesis) is malonyl-CoA dependant and biosynthetic module 2 (naringenin conversion into kaempferol) is NADPH dependant<SUP>6</SUP>.  
</P><P>
Dividing these two functional enables the metabolic equilibrium within each strain to be optimized for the specific module, maximizing the efficiency of energy utilization by the cell.

         </P></DIV><DIV class="row"><OL><P style="color: grey; font-size: 13pt; margin-left: 80px;">References</P><LI>Zhang, H. and X. Wang, Modular co-culture engineering, a new approach for metabolic engineering. Metabolic Engineering, 2016. 37: p. 114-121.</LI><LI>Zhang, H., et al., Engineering Escherichia coli coculture systems for the production of biochemical products. Proceedings of the National Academy of Sciences, 2015. 112(27): p. 8266.</LI><LI>Duan, L., et al., Biosynthesis and engineering of kaempferol in Saccharomyces cerevisiae. Microbial Cell Factories, 2017. 16: p. 165.</LI><LI>Jones, J.A., et al., Complete Biosynthesis of Anthocyanins Using E. coli Polycultures. mBio, 2017. 8(3).</LI><LI>Ganesan, V., et al., Heterologous biosynthesis of natural product naringenin by co-culture engineering. Synthetic and Systems Biotechnology, 2017. 2(3): p. 236-242.</LI><LI>Jones, J.A., et al., Experimental and computational optimization of an Escherichia coli co-culture for the efficient production of flavonoids. Metabolic Engineering, 2016. 35: p. 55-63.</LI></OL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>